Immuno-Biological Laboratories Co. Mutual Funds

Health Care & Life Sciences » Biotechnology | Immuno-Biological Laboratories Co. Ltd.

Immuno-Biological Laboratories Co. Ltd. | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Nikko Asset Japan Emerging Equity Open

97,999

1.15%

-1

0.63%

12/18/2017

View Profile

Address	1091-1 Naka Aza-Higashida Fujioka Gumma 375 Japan
Employees	-
Website	http://www.ibl-japan.co.jp
Updated	09/14/2018
Immuno-Biological Laboratories Co., Ltd. engages in the manufacture and sale of antibody-related reagents and pharmaceutical products. It operates through the following segments: Diagnostics and Reagents, Genetically Modified Silkworm, Testing, and Cosmetics-related. The Diagnostics and Reagents segment deals with the research and development of reagents and pharmaceutical products as well as in vitro diagnostic pharmaceuticals.